# Dulaglutide vs tirzepatide in SURPASS J-mono: HbA1c, weight

Source: https://pepvault.app/research/dulaglutide-surpass-j-mono-2022

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Dulaglutide](https://pepvault.app/research#dulaglutide)

Randomized trial · people

# Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this Japanese trial, dulaglutide 0.75 mg lowered blood sugar but did little to body weight, and tirzepatide lowered both more, with more nausea.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 636
- **Published:** 2022
- **Journal:** Lancet Diabetes Endocrinol

## What they tested

The team tested whether weekly tirzepatide at 5, 10 or 15 mg controlled blood sugar and body weight better than weekly dulaglutide 0.75 mg in Japanese people with type 2 diabetes.

## How the study was done

A double-blind (neither patients nor doctors knew who got which drug), randomized, phase 3 trial at 46 centers in Japan in 636 adults with type 2 diabetes who were new to treatment or had stopped a single oral diabetes drug. Equal-sized groups got one of four weekly shots for 52 weeks: dulaglutide at 0.75 mg, or tirzepatide at a dose of 5 mg, 10 mg or 15 mg.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking dulaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 52, HbA1c (a 3-month average of blood sugar) fell by 1.3 in the dulaglutide arm, compared with 2.4, 2.6 and 2.8 in the tirzepatide 5, 10 and 15 mg arms. Against dulaglutide, the extra drop with tirzepatide ranged from 1.1 to 1.5 (all p<0.0001). Body weight changed by -0.5 kg (-0.7%) with dulaglutide, versus -5.8 kg, -8.5 kg and -10.7 kg (-7.8%, -11.0% and -13.9%) across the tirzepatide arms. Nausea affected 8% of the dulaglutide group and 12% to 20% of the tirzepatide groups; constipation affected 11% versus 14% to 18%.

## What it doesn’t show

Dulaglutide was tested only at 0.75 mg, and the trial included only Japanese adults, about three quarters of them men, for 52 weeks. It was funded by Eli Lilly and Company.

## The paper

Inagaki et al. Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial. Lancet Diabetes Endocrinol. 2022.

- [PubMed (PMID 35914543)](https://pubmed.ncbi.nlm.nih.gov/35914543/)
- [The paper (DOI 10.1016/S2213-8587(22)00188-7)](https://doi.org/10.1016/S2213-8587%2822%2900188-7)
- [ClinicalTrials.gov (NCT03861052)](https://clinicaltrials.gov/study/NCT03861052)

## The compounds

- [Dulaglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/dulaglutide)
- [Tirzepatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/tirzepatide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

## With this study

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 7 studies](https://pepvault.app/research#dulaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [All 15 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

## More studies on Dulaglutide

- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026) Randomized trial · people · 2026
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025) Randomized trial · people · 2025
- [Dulaglutide lowered major cardiovascular events (HR 0.88) in REWIND](https://pepvault.app/research/dulaglutide-rewind-2019) Randomized trial · people · 2019
- [Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018) Randomized trial · people · 2018
- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024) Animal study · mice · 2024
- [MOTS-c prevented muscle atrophy, raised muscle glucose uptake in mice](https://pepvault.app/research/mots-c-kumagai-2024) Animal study · mice · 2024
- [Every study on Dulaglutide](https://pepvault.app/research#dulaglutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking dulaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking dulaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 7 studies](https://pepvault.app/research#dulaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [All 15 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

<!--promo-->

PepVault for iPhone

## Taking dulaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Dulaglutide](https://pepvault.app/research#dulaglutide)

## The library

- [Dulaglutide](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)
- [Tirzepatide](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
